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temporal lobe epilepsy
Abstract
Temporal lobe epilepsy (TLE) is associated with impaired inhibitory neurotransmission. Studies in
animal models suggest that GABA(A) receptor dysfunction contributes to epileptogenesis. To
understand the mechanisms underlying TLE in humans, it is fundamental to determine whether and how
GABA(A) receptor subtypes are altered. Furthermore, identifying novel receptor targets is a prerequisite
for developing selective antiepileptic drugs. We have therefore analyzed subunit composition and
distribution of the three major GABA(A) receptor subtypes immunohistochemically with
subunit-specific antibodies (alpha1, alpha2, alpha3, beta2,3, and gamma2) in surgical specimens from
TLE patients with hippocampal sclerosis (n = 16). Profound alterations in GABA(A) receptor subtype
expression were observed when compared with control hippocampi (n = 10). Although decreased
GABA(A) receptor subunit staining, reflecting cell loss, was observed in CA1, CA3, and hilus, the
distinct neuron-specific expression pattern of the alpha-subunit variants observed in controls was
markedly changed in surviving neurons. In granule cells, prominent upregulation mainly of the
alpha2-subunit was seen on somata and apical dendrites with reduced labeling on basal dendrites. In
CA2, differential rearrangement of all three alpha-subunits occurred. Moreover, there was layer-specific
loss of alpha1-subunit-immunoreactive interneurons in hippocampus proper, whereas surviving
interneurons exhibited extensive changes in dendritic morphology. Throughout, expression patterns of
beta2,3- and gamma2-subunits largely followed those of alpha-subunit variants. These results
demonstrate unique subtype-specific expression of GABA(A) receptors in human hippocampus. The
significant reorganization of distinct receptor subtypes in surviving hippocampal neurons of TLE
patients with hippocampal sclerosis underlines the potential for synaptic plasticity in the human GABA
system.
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Temporal lobe epilepsy (TLE) is associated with impaired inhibi-
tory neurotransmission. Studies in animal models suggest that
GABAA receptor dysfunction contributes to epileptogenesis. To
understand the mechanisms underlying TLE in humans, it is
fundamental to determine whether and how GABAA receptor
subtypes are altered. Furthermore, identifying novel receptor
targets is a prerequisite for developing selective antiepileptic
drugs. We have therefore analyzed subunit composition and
distribution of the three major GABAA receptor subtypes immu-
nohistochemically with subunit-specific antibodies (a1, a2, a3,
b2,3, and g2) in surgical specimens from TLE patients with
hippocampal sclerosis (n 5 16). Profound alterations in GABAA
receptor subtype expression were observed when compared
with control hippocampi (n 5 10). Although decreased GABAA
receptor subunit staining, reflecting cell loss, was observed in
CA1, CA3, and hilus, the distinct neuron-specific expression
pattern of the a-subunit variants observed in controls was mark-
edly changed in surviving neurons. In granule cells, prominent
upregulation mainly of the a2-subunit was seen on somata and
apical dendrites with reduced labeling on basal dendrites. In
CA2, differential rearrangement of all three a-subunits occurred.
Moreover, there was layer-specific loss of a1-subunit-
immunoreactive interneurons in hippocampus proper, whereas
surviving interneurons exhibited extensive changes in dendritic
morphology. Throughout, expression patterns of b2,3- and g2-
subunits largely followed those of a-subunit variants. These
results demonstrate unique subtype-specific expression of
GABAA receptors in human hippocampus. The significant reor-
ganization of distinct receptor subtypes in surviving hippocampal
neurons of TLE patients with hippocampal sclerosis underlines
the potential for synaptic plasticity in the human GABA system.
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Fast synaptic inhibition in the vertebrate CNS is mediated primar-
ily by the neurotransmitter GABA interacting with the GABAA
class of receptors. Impaired GABA transmission can lead to neu-
ronal hyperexcitability, a condition associated with epileptogenesis.
Furthermore, antiepileptic agents that enhance GABAA receptor
function are effective in treating seizures (Olsen et al., 1999).
Temporal lobe epilepsy (TLE) is the most common adult seizure
disorder and, when associated with hippocampal sclerosis (HS), is
the most refractory to pharmacotherapy (Engel, 1998; Semah et al.,
1998). Evidence from human studies suggests that postsynaptic
GABAA receptors contribute to the pathophysiology of TLE with
HS. Thus, alterations in GABAA receptor function and in their
allosteric modulation by ligands of the benzodiazepine-binding site
were documented in hippocampal neurons from HS patients
(Franck et al., 1995; Williamson et al., 1995, 1999; Isokawa, 1996;
Shumate et al., 1998; Brooks-Kayal et al., 1999). Furthermore, in
vivo imaging and autoradiographic studies demonstrated a decrease
in central benzodiazepine receptor binding primarily attributed to
extensive cell death in the sclerotic hippocampus of TLE patients
(Olsen et al., 1992; Burdette et al., 1995; Koepp et al., 1996) and
additional reduction of receptor density per remaining neuron in
CA1 (Johnson et al., 1992; Hand et al., 1997; Koepp et al., 1998).
The recognition of multiple GABAA receptor subtypes and their
differential expression in distinct neuronal populations (Fritschy
and Mo¨hler, 1995; McKernan and Whiting, 1996; Sperk et al., 1997)
permits a target-oriented analysis of GABAA receptor dysfunction
in human TLE. GABAA receptor heterogeneity results from the
combinatorial assembly of a multitude of subunit variants encoded
by at least 20 genes (a1–6, b1–4, g1–3, d, e, p, u, and r1–3) (Mo¨hler
et al., 1996; Barnard et al., 1998; Whiting et al., 1999). If expression
of specific GABAA receptor subtypes is altered in TLE, their
identification would facilitate the development of more selective
antiepileptic drugs and ligands for in vivo imaging. Current ap-
proaches, however, have not provided the degree of spatial resolu-
tion and specificity required to characterize individual receptor
subtypes and their subunit-specific alterations in human brain.
Although recent studies in animal models of TLE reported
changes in the number and subunit composition of GABAA recep-
tors in hippocampal neurons (Schwarzer et al., 1997; Brooks-Kayal
et al., 1998; Nusser et al., 1998; Bouilleret et al., 2000), the validity
of these data as pertains to human TLE remains to be established.
In the present study, we investigated alterations in subunit archi-
tecture and localization of GABAA receptor subtypes in hip-
pocampi resected from TLE patients with HS and compared these
with control tissue obtained at autopsy and with specimens from
TLE patients without HS. A protocol based on microwave irradi-
ation and tyramide signal amplification was used to visualize the
major GABAA receptor subunits a1, a2, a3, b2,3, and g2 in human
brain tissue using subunit-specific antisera (Loup et al., 1998).
Parts of this paper have been published previously as abstracts
(Loup et al., 1997, 1999).
MATERIALS AND METHODS
Patient selection. Twenty-one patients (mean age, 34.9 6 2.5 years; range,
15–56 years) undergoing surgery for medically intractable TLE were
included in this study. All procedures were performed with consent of the
patients and were approved by the Ethics Committee of the University
Hospital Zurich in accordance with the Helsinki Declaration of 1975.
Presurgical assessment consisted of detailed history and neurological ex-
amination, semi-invasive EEG monitoring with foramen ovale electrodes,
and neuropsychological testing. Neuroradiological studies included for all
cases high-resolution magnetic resonance imaging (MRI) with special
protocols to visualize the hippocampal formation and positron emission
tomography (PET) with 18fluoro-2-deoxyglucose. Intraoperative electro-
corticography was performed in all subjects to further characterize the
Received March 14, 2000; revised May 3, 2000; accepted May 3, 2000.
This work was supported by the The´odore OTT Fund (F.L.) and Swiss National
Science Foundation Grant 31–52869.97 (J.M.F.). We are grateful to Prof. Hanns
Mo¨hler for his continuous support and we thank Dr. Florence Crestani for advice on
statistics and Dr. Urs Gerber for comments on this manuscript.
Correspondence should be addressed to Dr. Fabienne Loup, Institute of Pharma-
cology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
E-mail: loupf@pharma.unizh.ch
Copyright © 2000 Society for Neuroscience 0270-6474/00/205401-19$15.00/0
The Journal of Neuroscience, July 15, 2000, 20(14):5401–5419
epileptogenic zone to be resected. Based on clinical, EEG, neuroimaging,
and neuropathological data, patients were classified into those with HS
(n 5 16; mean age, 36.9 6 2.7 years; range, 17–56 years) and those without
HS (non-HS; n 5 5; mean age, 28.2 6 5.6 years; range, 15–44 years)
(Wieser et al., 1993). Patients from the HS group underwent selective
amygdalohippocampectomy consisting in resection of amygdala, hip-
pocampal formation, and parahippocampal gyrus (Wieser and Yasargil,
1982). The HS group included patients with severe damage to the hip-
pocampus as assessed by MRI and PET studies, with the epileptogenic
focus localized to the mesial temporal region, and, in most cases, with a
history of seizures from childhood. The origin of TLE in the non-HS
patients was attributed to a tumor (n 5 3) or vascular malformation (n 5
1) identified by neuroimaging in an extrahippocampal location and con-
firmed histopathologically, and in one case no lesion was apparent. In these
patients, the surgical procedure consisted of amygdalohippocampectomy
alone or with resection of the epileptogenic lesion or part of temporal lobe.
For comparison, hippocampi from five subjects (mean age, 58 6 6.2 years;
range, 40–73 years) with no history of neurological or psychiatric disorder
were collected at autopsy between 8 and 16 hr after death (mean postmor-
tem interval, 11.2 6 1.3 hr). Hippocampal tissue was also obtained from a
56-yr-old patient with known TLE and HS with a postmortem interval of
15 hr, who had died from multiorgan failure.
Tissue preparation. Hippocampal specimens obtained at surgery or au-
topsy were cut into 7- to 12-mm-thick blocks transversely to the long axis.
In surgical TLE cases, the rostrocaudal extent of the hippocampus avail-
able for study ranged from 7.2 to 17.6 mm for HS specimens (mean length,
12.6 6 0.75 mm) and from 8 to 12 mm for non-HS specimens (mean length,
9.6 6 0.72 mm). For all specimens, the sampled part of hippocampus
comprised rostral and middle levels. When tissue was obtained at autopsy,
the whole hippocampus was collected. After rinsing in PBS at pH 7.4
immediately on resection in the operating room or after dissection at
autopsy, tissue blocks were immersion-fixed for 6–8 hr at 4°C under
constant agitation in a mixture of 4% freshly dissolved paraformaldehyde
and 15% saturated picric acid in 0.15 M phosphate buffer at pH 7.4
(Somogyi and Takagi, 1982). After fixation, tissue blocks were pretreated
using a modified antigen-retrieval method based on microwave irradiation
as described previously (Fritschy et al., 1998) and adapted to human tissue
(for details, see Loup et al., 1998). Tissue blocks were cryoprotected in 10,
20, and 30% sucrose in PBS over a period of 3–4 d, frozen at 228°C in
isopentane, and stored at 280°C. Subsequently, series of 40-mm-thick
sections were cut in a cryostat and collected in ice-cold PBS. They were
then either processed for immunohistochemistry (see below) or trans-
ferred to antifreeze solution [50 mM phosphate buffer, 15% sucrose, 30%
(v/v) ethylene glycol, and sodium azide, pH 7.4] and stored at 220°C until
use. This procedure allowed 10–12 different specimens, including tissue
from autopsies, to be processed in parallel during the same session.
Staining for the GABAA receptor subunits was performed on consecutive
sections (five series), and the space between sections from one series was
between 720 and 800 mm. An additional adjacent series of sections was
Nissl-stained for histopathological examination.
Immunohistochemistry. The following subunit-specific antibodies were
used: mouse monoclonal antibodies bd-24 and bd-17 recognizing the
human GABAA receptor a1-subunit and both the b2- and b3-subunits,
respectively (Schoch et al., 1985; Ewert et al., 1990), and polyclonal guinea
pig antisera recognizing the a2-, a3- and g2-subunits (Loup et al., 1998).
The preparation and characterization of the polyclonal antibodies, raised
against synthetic peptides derived from rat cDNA sequences, have been
described (for details, see Fritschy and Mo¨hler, 1995). For each subunit,
the amino acid sequences used as antigens were found to be identical in rat
and human cDNAs, and the high specificity of the GABAA receptor
subunit antibodies in human brain tissue was verified with Western blot
analysis (Waldvogel et al., 1999). Free-floating sections were preincubated
in 1.5% H2O2 in PBS for 10 min at room temperature to block endogenous
peroxidase activity. They were then washed three times for 10 min in PBS
and processed for immunoperoxidase staining (Hsu et al., 1981) as de-
scribed previously (Loup et al., 1998). The dilutions of the antibodies were:
a1-subunit (monoclonal antibody bd-24), 0.2 mg/ml; a2-subunit (affinity-
purified), 1.3 mg/ml; a3-subunit (affinity-purified), 1.8 mg/ml; b2,3-subunit
(monoclonal antibody bd-17), 3.8 mg/ml; and g2-subunit (crude serum),
1:1500. Control experiments for staining specificity included the replace-
ment of primary antibodies with nonimmune serum and preadsorption of
the antibodies with 3–5 mg/ml of their respective peptide antigen (Fritschy
and Mo¨hler, 1995; Loup et al., 1998). No specific staining was seen in
either case. To assess the subcellular localization of GABAA receptor
subunits in individual neurons with confocal laser-scanning microscopy,
immunofluorescence staining with tyramide signal amplification (TSA kit;
NEN Life Science Products, Bru¨ssels, Belgium) was performed (Loup et
al., 1998).
Data analysis. Sections were analyzed with a Zeiss (Jena, Germany)
Axioplan microscope equipped for bright-field and epifluorescence micros-
copy. Photomicrographs were taken with Eastman Kodak (Rochester, NY)
T-max 100 film. Sections processed for immunofluorescence staining were
also analyzed by confocal laser-scanning microscopy (TCS 4D; Leica,
Heidelberg, Germany) using Imaris software (Bitplane, Zurich, Switzer-
land) for image processing.
Nomenclature. The nomenclature of Lorente de No´ (1934) was used
except for the hilar region where the classification proposed by Amaral
(1978) and later described for the human hippocampus was adopted
(Amaral and Insausti, 1990). Accordingly, the portion of the pyramidal
layer that inserts into the dentate hilus (CA3c and/or CA4 in the termi-
nology of Lorente de No´, 1934) is referred to as CA3.
Neuron counts. Nissl-stained sections from all specimens were examined
to assess the presence of pathological alterations in general and the degree
of hippocampal sclerosis in epileptic samples in particular. In addition,
neurons were counted in the regions where densitometric measurements of
GABAA receptor subunit staining intensity were obtained, using immedi-
ately adjacent Nissl-stained sections from autopsy (n 5 5), non-HS (n 5 5),
and HS cases (n 5 16). Nucleolar profiles of CA2 pyramidal cells and
nuclear profiles of granule cells were counted within a 12.5 3 12.5 mm
ocular grid consisting of 10 3 10 squares at a magnification of 400 and
10003, respectively. Four to six measurements per region and section were
averaged where all nuclei visible in the section were counted except for
those touching the top and right edges of the grid. Typically, in autopsy
and non-HS cases, the width of the granule cell layer was included in a
single counted field (125 3 125 mm area), whereas in HS cases with granule
cell dispersion, two or sometimes three fields were necessary to include all
granule cells. To account for this factor, granule cells were also counted
within a 125-mm-wide column through the granule cell and molecular
layers (Houser, 1990). Moreover, in some HS cases, granule cells displayed
elongated cell bodies that appeared larger. Therefore, no assumption-
based methods were used, and the results were expressed as mean number
of neuronal profiles per square millimeter and additionally, for granule
cells, per column. The counts were not performed in a stereological
manner, because the intention was to represent the distribution of these
neurons in relative terms suited for intergroup comparison and that such
procedures are not amenable to surgically collected tissue where random
sampling is difficult and tissue volume changes caused by hippocampal
sclerosis cannot be estimated.
The numbers of interneurons immunoreactive for the a1-subunit were
assessed in the CA2 and CA3 areas using the grid procedure described
above. Counts were done at a magnification of 2003 in strata pyramidale,
radiatum, and lacunosum-moleculare, and additionally for CA3, in stratum
lucidum. While strata pyramidale, lacunosum-moleculare, and lucidum did
not show signs of major atrophy in HS cases as measured by their respec-
tive widths, stratum radiatum had undergone variable and at times severe
reduction. For this reason and because the borders between strata were
readily delimited, counts were obtained within an area consisting of 625
mm 3 the thickness of the stratum where the cells were counted. Two to
three counts per stratum and region were made in two sections from each
specimen. In a few surgical cases, mostly non-HS, it was not possible to
obtain a1-subunit-positive interneuron counts in certain CA2 or CA3
strata because of damage during the resection procedure.
Densitometric measurements. Sets of six adjacent sections were consid-
ered for each case analyzed: one Nissl-stained and five immunostained
sections. The intensity of labeling for the GABAA receptor subunits a1,
a2, a3, b2,3, and g2 was measured by densitometry in sections from
autopsy (n 5 5), non-HS (n 5 3), and HS cases (n 5 14) at equivalent
midrostrocaudal levels of the hippocampus. Sections were imaged using a
high-resolution video camera (1280 3 1024 pixels) interfaced with a Zeiss
microscope under a 103 objective. Before conducting the measurements,
the computer-assisted imaging device MCID M5 (Imaging Research, St.
Catherines, Ontario, Canada) was calibrated with a set of neutral density
filters (Eastman Kodak) to automatically convert gray levels to optical
density values. I llumination and filter settings were maintained at the same
level for image acquisition and densitometric analysis for all specimens.
Optical density (OD) measurements were recorded in the CA2 area and
the dentate gyrus. For CA2 analysis, two rectangles with an area of 68,600
mm 2 each were used to measure the average OD per section in the
pyramidal cell layer. In the dentate gyrus, the average OD was calculated
from measurements in five circles with an area of 1020 mm 2 each in the
granule cell layer, the inner molecular layer, the outer molecular layer, and
the subgranular layer in both the upper and lower blades. Because the
epileptic samples contained no region where staining for one or more of
the GABAA receptor subunits was judged to be unequivocally unaffected,
the results were not normalized to a reference value. Variability was
greatly minimized, however, by the highly standardized tissue preparation
protocol and the immunohistochemical processing in parallel of 10–12
different samples from autopsy, non-HS, and HS cases.
Statistical analysis. Neuron counts and densitometric measurements were
analyzed for statistical significance using the Kruskal–Wallis test (non-
parametric ANOVA; InStat program). Data were further compared be-
tween individual groups (at p , 0.05) with a multiple comparisons test.
RESULTS
Patient history
Medical records from all seizure patients were reviewed for rele-
vant clinical parameters. Whereas no significant difference was
found for the age at surgery (HS group: 36.9 6 2.7 years, range,
17–56 years, n 5 16; non-HS group: 28.2 6 5.6 years, range, 15–44
years, n 5 5), seizures had lasted longer and usually started earlier
in HS patients compared with non-HS patients (duration of the
5402 J. Neurosci., July 15, 2000, 20(14):5401–5419 Loup et al. • Altered GABAA Receptor Subtypes in Human Epilepsy
epilepsy, defined as the interval between onset of habitual seizures
and surgical treatment: 28 6 2.7 years, range, 12–44 years vs 10.4 6
4.4 years, range, 2–26 years; age at seizure onset: 8.9 6 1.6 years,
range, 1–22 years vs 17.8 6 4.8 years, range, 9–30 years). A history
of an initial precipitating injury (Mathern et al., 1995a), was doc-
umented in 11 patients in the HS group and none in the non-HS
group. These events included febrile convulsions (n 5 6), infantile
meningitis/encephalitis (n 5 3), and neonatal anoxia/ischemia (n 5
2). Preoperatively HS and non-HS patients were on similar anti-
epileptic medication. Seizure control was assessed in all surgical
cases (mean follow-up period of 24 6 1.1 months). Postoperatively,
12 patients in the HS group (75%) were seizure-free (class 1, as
classified after Engel, 1987), two had rare seizures (class 2), and
two patients had worthwhile improvement (class 3). In the non-HS
group, four patients were seizure-free, and one patient was un-
changed. The high success rate in achieving seizure control indi-
cates that the epileptogenic focus was successfully removed with
selective amygdalohippocampectomy.
Comparison of patient categories
The distribution of the GABAA receptor subunits a1, a2, a3, b2,3,
and g2 was analyzed in hippocampal specimens from TLE patients
with HS (n 5 16). For comparison, two control groups were used
and defined as hippocampal tissue obtained at autopsy from pa-
tients with no evidence of neurological disease (n 5 5) and tissue
surgically removed from patients with TLE, but without HS (n 5
5). Both were indistinguishable on the basis of morphological
criteria except for at most mild neuronal loss in TLE without HS,
as reported in previous studies (Babb et al., 1984; Kim et al., 1990).
More importantly, the staining pattern for the GABAA receptor
subunits under study was largely similar in the two groups. This is
illustrated for the a1-subunit in Figure 1 where the postmortem
specimen from a 40-yr-old man with no known neurological disor-
der (top lef t panel) was compared with the surgical specimen from
a 45-yr-old-man with TLE secondary to a benign extrahippocam-
pal tumor and without HS (bottom lef t panel). The origin of control
specimens, whether from autopsy or surgery, is indicated in paren-
theses for each subsequent figure.
To test whether autopsy specimens represent valid controls for
surgical specimens, hippocampal tissue obtained at autopsy from a
patient with TLE and HS was compared with tissue obtained at
surgery from patients suffering from TLE with HS, as shown for
GABAA receptor a1-subunit staining (Fig. 1). Although the au-
topsy specimen was processed after a 15 hr postmortem interval
(top right panel) and the surgical specimen immediately after re-
Figure 1. Validation of controls. Hippocampal tissue obtained at autopsy does not differ from hippocampal tissue removed surgically with respect to
GABAA receptor immunoreactivity. These examples show a1-subunit staining: autopsy control, without neurological disease (top lef t), surgical control,
TLE without HS (bottom lef t), autopsy, TLE with HS (top right), and surgery, TLE with HS (bottom right). Note that GABAA receptor a1-subunit staining
pattern and intensity in the TLE specimen without HS are comparable to those in the autopsy control, yet markedly different from both TLE specimens
with HS. DG, Dentate gyrus; H, dentate hilus; S, subiculum. Scale bar, 1 mm.
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section (bottom right panel), staining patterns were comparable,
confirming that GABAA receptor subunit antigens are stable for
several hours after death (Loup et al., 1998).
Regional distribution of GABAA receptor subunits in
controls and TLE with HS
To provide an overview, GABAA receptor subunits a1, a2, a3,
b2,3, and g2 in the human hippocampus were visualized at low-
power magnification in color-coded video images (Fig. 2). Differ-
ences in staining intensity for each subunit were assessed using a
normalized scale. In rodent brain, these subunits account for at
least 80% of all GABAA receptors (for review, see McKernan and
Whiting, 1996; Mo¨hler et al., 1996). Whereas the b2,3- and g2-
subunits are part of most GABAA receptor subtypes, the a-subunit
variants represent largely distinct subtypes with a specific pharma-
cological profile and distribution pattern. A similar organization in
subunit architecture was observed in normal human hippocampus.
In control specimens (Fig. 2, first column), the b2,3- and g2-
subunits exhibited a comparable labeling pattern, with staining
intensity being highest in the dentate molecular layer and CA1, and
moderate in CA2, CA3, and hilus. Autoradiographic studies with
benzodiazepine radioligands have described a similar distribution
of GABAA receptors, confirming the ubiquitous nature of these
two subunits (Faull and Villiger, 1988; Houser et al., 1988; Hand et
al., 1997). In contrast, the a-subunit variants showed distinct pat-
terns of immunoreactivity (Fig. 2, third column). For the a1-
subunit, the density of immunolabeling was highest in the dentate
molecular layer and CA1. Staining was moderate in CA2 and hilus.
At this level of magnification, CA3 appeared nearly devoid of
a1-subunit immunoreactivity. These findings are in accordance
with a previous study in normal human tissue (Houser et al., 1988).
Immunoreactivity for the a2-subunit was most abundant in the
dentate molecular layer. Labeling was also prominent in CA2,
CA3, and hilus, and moderate in CA1, a pattern similar to that
reported in rodents (Fritschy and Mo¨hler, 1995). Finally, specific
a3-subunit immunoreactivity was consistently found to be highest
in CA1, moderate to low in CA2, and virtually absent in CA3 and
hilus, whereas in the dentate gyrus immunolabeling varied among
specimens (see Fig. 13E,F). Figure 2 illustrates a case with low
a3-subunit immunoreactivity in the dentate molecular layer.
In TLE with HS specimens (Fig. 2, second and fourth columns),
the characteristic pattern of gliosis and regional neuronal loss was
revealed with Nissl staining. Cell death was most extensive in CA1
and more moderate in CA3 and dentate hilus, with areas of relative
sparing in CA2 and dentate gyrus. Two main alterations in
GABAA receptor subunit expression were observed at the regional
level. First, areas of prominent cell loss, such as CA1, CA3, and
dentate hilus showed marked reduction in immunoreactivity for all
subunits. These changes closely paralleled the pattern of neuronal
loss occurring in HS. Second, areas of relative cell loss, such as CA2
and the dentate gyrus, exhibited subunit-specific, increased or
decreased intensity of staining in comparison to controls, suggest-
ing corresponding changes in the number of receptors in surviving
principal cells. Upregulation was most prominent for the a2-
subunit. Differences in staining intensity between HS specimens
and the two control groups were assessed by quantitative densitom-
etry in the CA2 pyramidal cell layer and dentate layers (Fig. 3, see
below). In the following, results will be described in subregions of
the hippocampus in controls and TLE specimens with HS. Unless
Figure 2. Cytoarchitecture and regional distribution of the major GABAA receptor subunits in the hippocampus from a control (autopsy, first and third
columns) and a TLE patient with HS (second and fourth columns). Optical density of staining is color-coded according to a normalized scale showing the
strongest signal in white and the background in dark blue. In both specimens, adjacent sections were stained for the subunits a1, a2, a3, b2,3, and g2, and
for Nissl. In the control, Nissl staining shows a normal distribution of neuronal cell somata. Labeling for the b2,3- and g2-subunits is largely similar,
whereas each a-subunit has a differential distribution pattern. In TLE with HS, Nissl staining reveals prominent cell loss in CA1, CA3, and dentate hilus
with relative sparing of the dentate granule cell layer and granule cell dispersion. The CA2 and partly CA3 pyramidal cell layer is not shown in this section,
but is visible in those stained for the a-subunits. The decrease in GABAA receptor subunit immunoreactivity parallels cell loss in CA1, CA3, and dentate
hilus, whereas staining is increased or decreased in a subunit-specific manner in CA2 and dentate gyrus. The magenta spots in the dentate hilus represent
surviving mossy cells. Scale bar, 2 mm.
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otherwise mentioned, the distribution of the ubiquitously present
b2,3- and g2-subunits largely paralleled that found for the
a-subunit variants and will not be described further.
GABAA receptor subtypes in the CA1 area
Control specimens
Within CA1, a laminar pattern was observed for all subunits, as
illustrated in Figure 4A for the a2-subunit and Figure 4D for the
a1-subunit. Stratum pyramidale showed highest intensity and strata
oriens and lacunosum-moleculare moderate intensity of staining.
Because of the fused hippocampal fissure, labeling of stratum
lacunosum-moleculare often appeared continuous with that of the
dentate molecular layer (Fig. 4A). The more lightly stained band
represented stratum radiatum. Immunoreactivity was diffusely
present throughout the pyramidal cell and dendritic layers. At high
magnification, individual pyramidal neurons could be discerned,
outlined by discrete staining along the surface of the somata and
proximal dendrites (data not shown; Loup et al., 1998). Among all
subunits, a3-subunit immunoreactivity was highest, a finding that
contrasts with data from rodents, in which a3-subunit staining is
absent in CA1 (Fritschy and Mo¨hler, 1995; Sperk et al., 1997).
An important additional feature of a1-, and less prominently
b2,3- and g2-subunit immunoreactivity in the hippocampus was the
intense labeling of numerous nonpyramidal cells. Based on their
size, location, and dendritic arborization, several types of interneu-
rons could be distinguished. Because of the strong neuropil stain-
ing in CA1, it was not always possible, however, to identify them all.
In stratum oriens, somata of many immunoreactive neurons were
fusiform with long dendrites that ran parallel to the alveus, or
round with few, short dendrites. These cells were superimposed on
a dense network of immunoreactive dendrites. In stratum pyrami-
dale, large and intensely stained multipolar cells were seen with
their dendrites passing through the strata pyramidale and radiatum
before entering the stratum lacunosum-moleculare (Fig. 5A). Most
conspicuous was the presence of small round interneurons, which
were especially numerous in stratum lacunosum-moleculare (Fig.
4D). Their radially oriented dendrites, forming a fine network
superimposed on diffuse neuropil, conferred a stellate-like aspect
to these cells.
TLE specimens with HS
In this series, three of 16 specimens showed segmental conserva-
tion of the CA1 pyramidal cell layer (Figs. 2, 4B), in which atrophy
was partial, and the staining pattern in the preserved area was
similar to that of control specimens. In the other 13 specimens,
there was marked atrophy of the CA1 area (Fig. 4C, a2-subunit, E,
a1-subunit). Whereas strata pyramidale and radiatum were re-
duced to a thin band virtually devoid of pyramidal cells, stratum
lacunosum-moleculare largely retained its original size. The few
surviving pyramidal cells were faintly immunoreactive for GABAA
receptors (data not shown).
In the absence of immunoreactivity in the dendritic fields of the
degenerated pyramidal cells, the interneurons expressing the a1-
subunit were revealed in all specimens (Figs. 4E, 5B,C). In stratum
oriens, fusiform, round, and multipolar interneurons could be
observed within a dense network of dendrites (Fig. 4E). In strata
pyramidale and radiatum, several types of nonpyramidal cells could
be distinguished with somata that were small and round, medium-
sized, or large and multipolar. The latter cell type frequently
displayed irregular soma conformations and dendrites that ap-
peared tangled, nodulated, variable in their diameters, and in-
creased in number (Fig. 5B,C). Finally, stratum lacunosum-
moleculare contained numerous small interneurons whose
dendrites formed a more intricate network than that observed in
controls. Occasional round cells of moderate size were also seen
(Fig. 4E).
Because of prominent neuropil labeling in control tissue, which
largely prevented counts of a1-subunit-positive interneurons in the
different strata, it was not possible to evaluate the extent, if any, of
interneuron loss that had occurred in HS specimens. As illustrated
in Figure 4E, however, interneurons present in strata pyramidale
and radiatum were consistently less numerous than in stratum
lacunosum-moleculare in the CA1 area.
GABAA receptor subtypes in the CA2 area
Control specimens
A subunit-specific pattern of staining was observed in the CA2
area. The a2-subunit exhibited a laminar distribution comparable
to that in CA1, with intense staining in stratum pyramidale and
lightest staining in stratum radiatum (Figs. 2, 6C). a3-Subunit
immunoreactivity was very different, in that it mainly outlined the
cell bodies of a few pyramidal neurons in the superficial aspect of
the stratum pyramidale. In stratum radiatum, their lightly labeled
apical dendrites formed delicate processes that ran parallel to one
another and entered the stratum lacunosum-moleculare where
staining was more diffuse (Fig. 6E). A laminar pattern was also
seen for the a1-subunit (Figs. 1, 2, 7A).
In addition, as in CA1, a1-subunit immunoreactivity revealed a
population of interneurons that were readily visible because of the
low to moderate a1-subunit-positive neuropil in CA2. In stratum
oriens, strong immunolabeling of fusiform and large multipolar
somata was detected. Their dendrites mostly ran parallel to the
alveus and frequently formed a dense fiber network. In stratum
pyramidale, three types of nonpyramidal neurons were identified
(Fig. 7A,D): (1) large, intensely stained multipolar interneurons
with long apical and basal dendrites, (2) medium-sized, oviform
cells with apical dendrites that could be followed into stratum
radiatum, and (3) small round interneurons. In stratum radiatum, a
few round and medium-sized a1-subunit-positive interneurons
were seen. In addition, strongly stained individual, or fascicles of,
dendritic processes passed through stratum radiatum and entered
Figure 3. Mean neuronal cell counts and densitometric measurements 6
SEM in autopsy (white bars), non-HS (shaded bars), and HS (black bars)
patient groups. A–G, Sets of six immediately adjacent sections were stained
for Nissl and the subunits a1, a2, a3, b2,3, and g2. A, B, Densities of CA2
pyramidal cells (A) and granule cells (B). C–G, Optical density measure-
ments in CA2 pyramidal cell layer (C), granule cell layer (D), inner
molecular layer (E), outer molecular layer (F), and subgranular layer (G).
H, I, Numbers of a1-subunit-positive interneurons per 625-mm-wide column
through each stratum in CA2 (H ) and CA3 ( I ). Nonparametric ANOVA p
values are presented above data set, and significant post hoc results are
indicated by asterisks ( p , 0.05). *Difference compared to the autopsy or
non-HS groups; **difference compared to the autopsy and non-HS groups.
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Figure 4. Subunit-specific GABAA receptor immunoreactivity in the CA1 area of controls (A, D, autopsy) as compared to TLE with HS (B, C, E). A, D,
Control sections exhibit a laminar staining pattern for the a2- and a1-subunits, respectively. Whereas immunoreactivity for both subunits is diffusely
distributed in neuropil, a1-subunit immunoreactivity is also present in numerous nonpyramidal neurons (D, arrows). B, C, Sections from two HS specimens
stained for the a2-subunit, where in B the partly conserved CA1 pyramidal cell layer shows a2-subunit immunoreactivity, and in C there is almost complete
pyramidal cell loss associated with severe atrophy of the CA1 area. E, Section from an HS specimen stained for the a1-subunit, showing the loss of neuropil
staining and the layer-specific distribution of nonpyramidal neurons. Whereas small interneurons are conserved in stratum lacunosum-moleculare and larger
interneurons in stratum oriens, few interneurons are visible in strata pyramidale and radiatum. Note the increase in GABAA receptor a2- and a1-subunit
expression in dentate molecular and granule cell layers in HS specimens. al, Alveus; gcl, dentate granule cell layer; H, dentate hilus; hf, hippocampal fissure;
ml, dentate molecular layer; slm, stratum lacunosum-moleculare; so, stratum oriens; sp, stratum pyramidale; sr, stratum radiatum. Scale bar, 200 mm.
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stratum lacunosum-moleculare (Fig. 7A). Stratum lacunosum-
moleculare contained a number of small stellate-shaped interneu-
rons with four to eight dendrites forming a delicate network against
a lightly stained diffuse neuropil (Fig. 7A,G). At the border be-
tween stratum lacunosum-moleculare and the dentate molecular
layer, occasional medium-sized cells were observed with smooth
dendrites oriented in a horizontal plane (data not shown).
TLE specimens with HS
Considerable reorganization in GABAA receptor subtype distri-
bution was observed in the CA2 area. Despite an average 40% loss
in pyramidal cells (Figs. 3A, 6B), stronger a2-subunit immunore-
activity than in control tissue was present in the surviving pyrami-
dal cells and dendritic fields (Fig. 6D). At high-power magnifica-
tion, intense staining was seen to outline their somata, which were
frequently deformed in shape and arranged in a disorganized
manner. Furthermore, a striking rearrangement of a3-subunit im-
munoreactivity occurred. Intense immunolabeling adorned indi-
vidual thickened apical dendrites passing through stratum radia-
tum, whereas pyramidal cell bodies were virtually unstained (Fig.
6F). Tangentially cut processes could be observed in strata radia-
tum and lacunosum-moleculare, indicating a change in direction of
some apical dendrites along the rostrocaudal axis.
Alterations in a1-subunit immunoreactivity markedly differed in
pyramidal versus nonpyramidal cells. Pyramidal cells and dendritic
layers displayed decreased and more diffuse staining in comparison
to control tissue (Figs. 1, 7B,C). In contrast, extensive layer-specific
changes in a1-subunit-positive interneurons were seen for all HS
specimens. In strata pyramidale and radiatum, profound loss of the
small, round and medium-sized interneurons immunopositive for
the a1-subunit was observed (Fig. 7B,C,E), whereas the large
multipolar nonpyramidal cells remained for the most part. How-
ever, their somata were deformed, and the dendritic arborization
was altered (Fig. 7E,F). In contrast, in stratum lacunosum-
moleculare the numerous small, round interneurons were pre-
served and surrounded by a dense dendritic network (Fig.
7B,C,H,I). Furthermore, the fusiform somata of interneurons
present at the border between stratum lacunosum-moleculare and
the dentate outer molecular layer frequently appeared larger and
more irregular than in control tissue, and their dendrites were
more prominent.
Quantitative analysis
In addition to neuron counts performed in adjacent Nissl-stained
sections (Fig. 3A), differences in staining intensity between the
autopsy, non-HS, and HS groups were assessed quantitatively by
densitometry for each of the five subunits in the CA2 pyramidal cell
layer (Fig. 3C). The following observations were made: (1) HS
specimens showed decreased neuron densities when compared to
autopsy ( p , 0.01), and a similar trend was observed when com-
pared with non-HS cases, whereas the difference between the
autopsy and non-HS groups was not significant. (2) There were
subunit-specific differences in OD for the a-subunit variants a1, a2,
and a3. Compared with the autopsy group, a2-subunit OD in HS
was significantly increased ( p , 0.01), whereas OD for the a1- and
a3-subunits was significantly decreased ( p , 0.05, p , 0.01, respec-
tively). Furthermore, OD for the a1- and a3-subunits was signifi-
cantly decreased compared to the non-HS group ( p , 0.01, p ,
0.05, respectively). (3) No significant difference in OD was found
for all three a-subunit variants between the autopsy and non-HS
groups. (4) As for the ubiquitously present b2,3- and g2-subunits,
no significant difference in OD was found between the three patient
categories, which may reflect a change in receptors containing these
subunits, whereby a decrease in one subtype of receptor (a1 or a3)
is compensated for by an increase in another (a2). These findings
suggest that while the total number of receptors may not change
significantly in the CA2 area in HS specimens, the relative propor-
tion of a2-subunit-containing GABAA receptors is markedly
increased.
To verify the observed loss or preservation of a1-subunit-
positive interneurons in specific strata, counts were performed in
625-mm-wide columns through each stratum in the three patient
categories (Fig. 3H). In strata pyramidale and radiatum, the HS
group showed decreased numbers of a1-subunit-positive interneu-
rons when compared with the autopsy or non-HS specimens (stra-
tum pyramidale: p , 0.01, p , 0.05, respectively; stratum radiatum:
p , 0.05 for both). In contrast, in stratum lacunosum-moleculare,
the number of a1-subunit-positive interneurons was not signifi-
cantly different in the HS group when compared with the autopsy
and non-HS specimens. For all strata, no significant difference in
interneuron counts was found between the autopsy group and
non-HS cases. These statistical data confirm the observation that,
Figure 5. Altered morphology of large multipolar interneurons immunoreactive for the a1-subunit in the CA1 pyramidal cell layer in TLE with HS. A,
In the autopsy control, soma contours are smooth with few long and straight dendrites. B, C, In HS specimens, the soma exhibits an irregular shape, and
dendrites appear tangled, variable in their diameters, and increased in number. At higher magnification (C), dendritic nodulations are visible (arrows).
Note the absence of a1-subunit staining in neuropil reflecting severe pyramidal cell loss in CA1. Scale bar: A, B, 50 mm; C, 25 mm.
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in the HS group, a significant number of a1-subunit-positive inter-
neurons are lost in strata pyramidale and radiatum while they are
preserved in stratum lacunosum-moleculare.
GABAA receptor subtypes in the CA3 area
Control specimens
In the CA3 area, abundant a2-subunit immunoreactivity was dis-
tributed in a laminar pattern largely similar to that in CA1 and CA2
(Fig. 8A). Neuropil staining was, however, more prominent and less
diffuse, except in strata radiatum and lucidum where it was fainter.
Immunolabeling for the a3-subunit was virtually absent (Fig. 2).
Likewise, faint or no a1-subunit staining was observed on the
pyramidal cell bodies and dendritic fields (Figs. 2, 9A). In contrast,
numerous interneurons expressing this subunit were detected in
CA3 (Figs. 8C,E, 9A). The types of nonpyramidal neurons labeled
and the distribution pattern in CA3 were largely similar to those in
CA2. Their darkly stained dendrites were of variable calibers,
usually running toward stratum lacunosum-moleculare and stratum
Figure 6. Subunit-specific alterations in GABAA receptor immunoreactivity in the CA2 area in controls (A, C, autopsy; E, surgery, TLE without HS)
versus TLE with HS (B, D, F ). A, B, Nissl-stained sections show moderate pyramidal cell loss in TLE with HS (B) as compared to control hippocampus
(A). C, D, a2-subunit immunoreactivity is increased in surviving pyramidal cells in TLE with HS (D) in comparison to controls (C). E, F, Redistribution
of a3-subunit immunoreactivity. In control hippocampus (E), staining is prominent, outlining the somata of a few pyramidal cells, but weak in their apical
dendrites, whereas in TLE with HS (F), thickened apical dendrites show intense immunoreactivity with virtually absent labeling of somata. Note the
tangentially cut dendrites reflecting disorganization in orientation (arrows). Abbreviations, see Figure 4. Scale bar, 100 mm.
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Figure 7. Layer-specific changes in interneurons stained for the GABAA receptor a1-subunit in the CA2 area in five different TLE specimens with HS
(B, C, E, F, H, I ) versus three different controls (A, G, autopsy; D, surgery, TLE without HS). A–C, Overview; D–F, stratum pyramidale; G–I, stratum
lacunosum-moleculare. A, D, G, In controls, several types of nonpyramidal cells are found in strata pyramidale and radiatum, whereas predominantly small
interneurons are present in stratum lacunosum-moleculare. B, C, In TLE with HS, the loss of interneurons in strata pyramidale and radiatum is either
extensive (B) or virtually complete (C), whereas the small interneurons are conserved in stratum lacunosum-moleculare. E, F, In stratum pyramidale,
surviving interneurons are large and display prominent somatic and dendritic alterations, whereas other types of interneurons are no longer apparent. H,
I, In stratum lacunosum-moleculare, the small interneurons are preserved, exhibiting an intricate dendritic network. Abbreviations, see Figure 4. Scale
bars: A–C,100 mm; D, E, 50 mm; F–I, 25 mm.
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oriens, but also without preferred direction. In addition, interneu-
rons with round to oval cell bodies and fine dendrites were ob-
served in stratum lucidum (Fig. 8C). Conspicuously, interneurons
were most numerous at the border between strata pyramidale and
lucidum.
TLE specimens with HS
In contrast to the increased GABAA receptor a2-subunit immuno-
reactivity described for the CA2 area, staining intensity for this
subunit paralleled the degree of pyramidal cell loss in CA3, sug-
gesting that no upregulation occurs in CA3 pyramidal cells (Fig.
8B). Considerable cellular disorganization was apparent in stratum
pyramidale, where somata were poorly aligned to each other and
exhibited various shapes. In three cases, pyramidal neurons were
largely preserved, and staining was similar to control tissue (data
not shown). In the other specimens, pyramidal cell loss was mod-
erate to severe and frequently segmental, mostly in the part of CA3
inserting into the dentate hilus (Fig. 8B).
Figure 8. Subunit-specific changes in GABAA receptor immunoreactivity in the CA3 area in controls (A, E, autopsy; C, surgery, TLE without HS) as
compared to TLE with HS (B, D, F ). A, B, a2-subunit, overview. C–F, a1-subunit with part of CA3 bordering CA2 (C, D) and part of CA3 inserting into
the dentate hilus (E, F ). A, A control section showing the laminar staining pattern with prominent labeling in stratum pyramidale and lighter labeling in
strata lucidum (sl ) and radiatum. B, Section from a HS specimen with segmental, moderate to light staining reflecting the moderate to severe pyramidal
cell loss. C, In the control, whereas different types of a1-subunit-positive interneurons are present in strata pyramidale and radiatum, small oviform neurons
are found in stratum lucidum. D, In TLE with HS, there is marked loss of interneurons in these strata. E, In stratum pyramidale of the control, large
multipolar interneurons with dendrites oriented perpendicularly to the pyramidal cell layer stand out against a fine dendritic network. F, In TLE with HS,
the few surviving interneurons located in stratum pyramidale have undergone extensive morphological transformation. Their fine dendrites appear
tangled, increased in number, and radially oriented. Abbreviations, see Figure 4. Scale bar: A, B, 200 mm; C–F, 100 mm.
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Layer-specific changes were observed for a1-subunit-positive
interneurons, which were comparable to those in CA2. Marked loss
of these interneurons was observed in strata pyramidale, lucidum,
and radiatum, and especially at the border between strata pyrami-
dale and lucidum (Fig. 8D). When large multipolar interneurons
were preserved in stratum pyramidale, their somata were fre-
quently encrusted with intense a1-subunit staining (Fig. 8F). In-
stead of exhibiting a few long dendrites oriented perpendicularly to
the pyramidal cell layer as in controls (Fig. 8E), these interneurons
displayed more numerous, shorter dendrites that ran in a radial
direction. In contrast, small, round interneurons morphologically
identical to those found in CA1 and CA2 were also preserved in
CA3 stratum lacunosum-moleculare.
Quantitave analysis
As in CA2, the numbers of a1-subunit-positive interneurons were
quantitatively assessed in distinct strata in the three patient groups
(Fig. 3I). Strata pyramidale and lucidum, however, were considered
together, because most interneurons were present at the border
between both strata and, therefore, could not be attributed unam-
biguously to one or the other stratum. In strata pyramidale-lucidum
and radiatum, the HS group showed decreased numbers of a1-
subunit-positive interneurons when compared with the autopsy or
non-HS specimens (stratum pyramidale-lucidum: p , 0.01, p ,
0.05, respectively; stratum radiatum: p , 0.01, p , 0.05, respec-
tively). In contrast, in stratum lacunosum-moleculare, the number
of a1-subunit-positive interneurons was not significantly different
in the HS group as compared to the autopsy or non-HS specimens.
For all strata, no significant difference in interneuron counts was
found between the autopsy group and non-HS cases. Thus, statis-
tically significant layer-specific changes in the number of a1-
subunit-positive interneurons in HS were present in CA3 as well.
GABAA receptor subtypes in the dentate hilus
Control specimens
In the dentate hilus, the GABAA receptor distribution pattern was
found to be subunit-specific, as in the hippocampal fields (Fig. 2).
The boundary between the hilus and CA3, which often is quite
difficult to delineate, was readily recognized as an abrupt transition
of a1-subunit staining. Thus, a1-subunit immunoreactivity was
moderate in dentate hilus but weak in CA3 (Figs. 2, 9A). In
contrast, a2-subunit immunoreactivity was of relatively similar
intensity in these two regions (Fig. 9B). Within the dentate hilus, a
trilaminate pattern was observed for both the a2- and a1-subunits,
as well as the ubiquitously present b2,3- and g2-subunits (Figs. 4A,
9A,B, 10D,G). First, a layer of prominent diffuse neuropil staining,
the subgranular layer, was observed immediately subjacent to the
granule cell layer and represented the basal dendrites of granule
cells (see “GABAA receptor subtypes in the dentate gyrus”).
Second, a weakly labeled neuron-sparse zone of variable thickness
could be identified. Third, a region that comprised the majority of
the hilar cells, the polymorphic layer, was situated deep to this
zone. In the case of a2-subunit staining, the hilar neurons fre-
quently appeared as white spots at low-power magnification, sur-
rounded by a moderately immunoreactive neuropil (Fig. 9B). In
contrast, a1-subunit-positive cell bodies and an associated network
of dendrites were intensely stained and surrounded by a moder-
ately to lightly immunoreactive neuropil (Figs. 9A, 10D).
The dentate hilus contains a variety of neuronal cell types with
unique morphological features, as reported in rat (Amaral, 1978)
and human brain (Braak, 1974; al-Hussain and al-Ali, 1995; Blu¨m-
cke et al., 1999). In the present study, a large number of hilar cells
immunopositive for either the a1-, a2-, or a3-subunit, or both the
a1- and a2-subunits were identified, based on the comparison of
adjacent sections stained for these subunits. Unexpectedly, previ-
ously undescribed pyramidal-shaped neurons immunoreactive for
the a2-subunit were observed well within the hilar borders. At
higher magnification, discrete staining occurred along the surface
of the somata and proximal dendrites, and intense staining re-
vealed darkly stained longitudinal processes 20- to 40-mm-long
(Fig. 10A). Using confocal laser-scanning microscopy, these struc-
tures were putatively identified as axon initial segments intensely
immunoreactive for the a2-subunit (Loup et al., 1998). The most
prominent type of hilar cell was the mossy cell, which exhibited
strong staining for both the a2- and a1-subunits (Fig. 10D; Loup et
al., 1998). The mossy cells were readily distinguished by the pres-
ence of characteristic “clusters of spheres” that form the mossy cell
thorny excrescences, as described by Amaral (1978). Finally, a
number of putative interneuron cell types immunopositive for the
a1-subunit were seen, including large multipolar cells. These were
localized in the polymorphic and subgranular layers (Fig. 10D,G),
and their dendrites traveled for long distances within the hilus or
ascended far into the dentate molecular layer. Occasionally large
multipolar interneurons with long dendrites were observed that
were stained lightly for the a3-subunit. Otherwise, no specific
staining was detected in the polymorphic layer for this subunit.
Figure 9. Differential distribution of a1- and a2-subunit immunoreactivity
in dentate hilus and CA3 in hippocampal tissue obtained at autopsy. A,
Moderate a1-subunit staining is present in the hilus, whereas the CA3 area
appears faintly labeled. The abrupt change in staining intensity allows the
boundary between the hilus and the CA3 area to be readily distinguished
(dashed line). B, In contrast, moderate a2-subunit staining is equally present
in both regions where the lighter spots represent neuronal cell bodies. Even
at this low-power magnification, a trilaminate pattern can be discerned
within the hilus. A and B are adjacent sections. Scale bar, 0.5 mm.
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Figure 10. Alterations in GABAA receptor a2- and a1-subunit immunoreactivity in the dentate hilus in TLE with HS (B, C, E, F, H, I ) versus controls
(A, D, autopsy; G, surgery, TLE without HS). a2-subunit (A–C), a1-subunit (D–I). A, In the control, a2-subunit labeling discretely outlines the somata
of pyramidal-shaped neurons (double arrows), whereas intense staining reveals their axon initial segments (large arrowheads). B, C, HS specimens. In B,
oval neurons with intense a2-subunit immunoreactivity along the somata resulting in a thickened outline are superimposed on decreased neuropil staining.
In C, a surviving medium-sized neuron exhibits a2-subunit staining against the white background because of severe loss of neuropil and cells. D, G, In
controls, light neuropil staining is present with several cell types immunoreactive for the a1-subunit, including mossy cells (arrows) and large multipolar
interneurons with long dendrites (small arrowheads). E, F, In TLE with HS, neuropil staining is absent, and cell loss has occurred; among the surviving
cells, mossy cells (E, arrows) and large interneurons with irregular somata and disorganized tangled dendrites can be recognized. G–I, The altered
morphology of large multipolar interneurons located in the subgranular layer is shown at higher magnification in two HS specimens (H, I ) as compared
to a control specimen (G). In TLE with HS, these interneurons often display changes in soma shape and dendritic arborization including coiling,
nodulation, strong variation in calibers, and increased ramification. Scale bar: A–C, I, 25 mm; D–F, 100 mm; G, H, 50 mm.
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TLE specimens with HS
In the polymorphic layer, the degree of neuronal loss was variable,
with cell loss being mild to moderate in five cases and severe in the
other specimens. In cases of lesser cell loss, the neuropil showed
decreased a2-subunit immunoreactivity, and round hilar cells
could be seen with their somata frequently outlined by intense
staining (Fig. 10B). These neurons were unstained for the a1-
subunit in adjacent sections (data not shown). In cases of marked
cell loss, staining intensity of the neuropil for both the a1- and the
a2-subunits was reduced to virtually nondetectable levels. Surviv-
ing hilar neurons and their dendritic network thus appeared darkly
stained against the pale background and were easily recognized
(Fig. 10C,E,F). Preserved cell types included: (1) a1- and a2-
subunit-positive mossy cells (Figs. 2, fourth column, 10E). Despite
severe loss, mossy cells were the most numerous among the sur-
viving a2-subunit-positive hilar neurons and represented a sizable
portion of the surviving a1-positive hilar neurons; (2) a2-subunit-
positive oviform cells with dendrites extending over long distances
(Fig. 10C); and (3) a1-subunit-positive large multipolar interneu-
rons, with irregular cell bodies and dendrites that appeared tan-
gled, nodulated, and increased in number (Fig. 10E,F,H,I). No
specific soma staining was visible for the a3-subunit against the
white background.
GABAA receptor subtypes in the dentate gyrus
Control specimens
Cell type-specific GABAA receptor subunit distribution was also
observed in the dentate granule cells. Staining for the a1-, a2-,
b2,3-, and g2-subunits was prominent in the apical dendritic field
forming the molecular layer and appeared stronger in the inner as
compared to the outer part (Fig. 2, first and third columns). The
dentate molecular layer displayed a higher intensity of staining
than any other area of the hippocampus (Fig. 2, first and third
columns). In the subgranular layer, diffuse moderate labeling was
observed in the basal dendritic field (Figs. 4A, 9A,B, 11A,C). In
contrast to the marked staining of both apical and basal dendritic
trees, labeling barely outlined the somata of the tightly packed
granule cells (Figs. 11A,C, 12, 13A,D). Whereas the a1-, a2-, b2,3,
and g2-subunits showed a largely similar distribution pattern in the
dentate gyrus of all specimens, a3-subunit expression was variable.
Despite similar intensity of staining in the CA1 area for all cases (as
exemplified in Fig. 2, third column), in granule cells this subunit
showed patchy labeling ranging from very weak (Fig. 11E) to high
levels of density (Fig. 11F) along the somata and basal and apical
dendritic fields. These case-specific variations were not dependent
on age, postmortem interval, or general quality of tissue, suggesting
a propensity for plasticity in a3-subunit immunoreactivity in den-
tate granule cells.
As in the hippocampal fields and dentate hilus, a1-, and less
prominently b2,3- and g2-subunit staining revealed nonpyramidal
cells in the granule cell and molecular layers. In particular, small
round interneurons similar to those described in stratum
lacunosum-moleculare of the hippocampus proper were observed.
Finally, darkly stained processes were frequently seen coursing
through the granule cell layer, originating from interneurons
mostly located in dentate hilus, but also in the granule cell and
molecular layers (Fig. 10D,G).
TLE specimens with HS
Marked alterations in the distribution pattern and staining inten-
sity of the a1-, a2-, b2,3-, and g2-subunits were observed in the
granule cell layer and dendritic fields. At low-power magnification,
the molecular layer displayed prominent staining, standing out
against the relatively weakly labeled hippocampal fields and hilus
(Figs. 1, 2). Staining appeared conserved or augmented when
compared to control specimens, despite a .50% loss in granule
cells (Fig. 3B), suggesting the presence of more GABAA receptors
on surviving apical dendrites. Of all subunits, a2 exhibited the
largest increase, as illustrated for eight cases (Figs. 2, fourth col-
umn, 12). For specimens with moderate granule cell loss, the
intensity of labeling measured in the molecular layer was higher
than that in control specimens. For specimens with severe granule
cell loss, the apparent intensity was similar to that in control
specimens. a1-, b2,3-, and g2-subunit immunoreactivity was con-
served or increased, but not as markedly (Figs. 1, 2, second and
fourth columns). In contrast, a3-subunit labeling was variable as in
the controls, being either faint (Fig. 11G) or intense (Fig. 11H). For
all subunits, changes in staining intensity were most pronounced in
the inner portion of the molecular layer along a thin band imme-
diately adjacent to the granule cell layer, where intensely labeled,
coarse dendrites were frequently observed at high-power magnifi-
cation (Figs. 11B,D,H, 13C).
In the basal dendritic field, reduced staining was observed for all
subunits. Immunoreactivity was decreased in seven cases, whereas
in the other nine cases, labeling was virtually absent, except for a
few stained dendrites, some of which reverted back into the granule
cell layer (Figs. 11B,D,H, 12, 13B,C). These two patterns of re-
duced immunoreactivity in the subgranular layer were not related
to the degree of cell loss in the polymorphic layer. Finally, the most
prominent changes were observed in the granule cell layer. Surviv-
ing granule cells exhibited increased staining for the a1-, a2-, b2,3-,
and g2-subunits, their somata varying in size and shape (Figs.
11B,D, 13B,C,E). At the subcellular level, individual granule cells
were outlined by intense staining along the surface of the cell
bodies (Fig. 13B,E) in contrast to discrete staining observed in
controls (Fig. 13A,D).
In conclusion, alterations in GABAA receptor subunit immuno-
reactivity in surviving granule cells show a remarkably polarized
pattern with increased staining on the soma membrane and apical
dendrites and decreased or no staining in the basal dendritic field.
The augmented staining in granule cell and molecular layers sug-
gests an upregulation of receptors in surviving granule cells of
TLE patients with HS, despite extensive granule cell loss. The
magnitude of changes in staining intensity observed in the granule
cells was most obvious for the a2-subunit.
Interneurons immunoreactive for the a1-subunit were mostly
conserved in the molecular layer with a preferential localization in
the outer part (Fig. 7C). Isolated, large and intensely stained cells
were also seen, with long dendrites reaching the outer molecular
layer and extending into the hilus. Because of loss of staining in the
granule cell basal dendrites, the few surviving interneurons were
easily identified in the subgranular layer (Fig. 10H,I).
Quantitative analysis
Granule cells were counted in Nissl-stained sections adjacent to
those used for densitometric measurements. Cell densities in HS
specimens were decreased by .50% compared to autopsy and
non-HS cases ( p , 0.01 for both), whereas no difference was found
between the autopsy and non-HS groups (Fig. 3B). This result was
not significantly changed when granule cell numbers were sampled
within a 125-mm-wide column to take into account dispersion of
granule cell somata (data not shown). Thus, in our HS patient
series, granule cell loss was extensive, whereas dispersion was
rather limited in most cases.
Differences in GABAA receptor subunit staining intensity be-
tween autopsy, non-HS, and HS groups were assessed quantita-
tively by densitometry (Fig. 3D–G). In the granule cell layer, the
HS group showed increased OD for the a1-, a2-, b2,3-, and g2-
subunits, when compared with autopsy specimens (a1- and b2,3-
subunits, p , 0.05; a2- and g2-subunits, p , 0.01). When compared
to non-HS cases, OD was significantly increased for the a2- and
b2,3-subunits in the HS group ( p , 0.05 for both). In the inner and
outer molecular layers, increased a2-subunit OD was observed in
the HS group when compared to autopsy cases ( p , 0.05, p , 0.01,
respectively). In contrast, in the subgranular layer, OD was signif-
icantly decreased for all subunits in the HS group when compared
either to autopsy specimens (a1-subunit, p , 0.01; a2-, a3- and
b2,3-subunits, p , 0.05) or to non-HS specimens (a1-, a2- and
b2,3- subunits, p , 0.05; g2-subunit, p , 0.01). In all layers, no
significant difference in OD was found for any of the five subunits
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Figure 11. Changes in subunit-specific GABAA receptor immunoreactivity in the dentate gyrus in TLE with HS (B, D, G, H ) versus controls (A, C,
surgery, TLE without HS; E, F, autopsy). A, B, a1-subunit; C, D, a2-subunit; E–H, a3-subunit. A, C, In control specimens, the somata of granule cells are
outlined by faint or no staining for the a1-subunit (A) and the a2-subunit (C), whereas apical and basal dendritic fields are moderately labeled. B, D, In
TLE with HS specimens, strongly increased a1-subunit (B) and a2-subunit immunoreactivity (D) is seen surrounding the somata of granule cells and in
the molecular layer, whereas only few basal dendrites remain. Note the granule cell dispersion into the molecular layer in HS (B, arrows). E, F, Two control
specimens illustrate the range of a3-subunit immunoreactivity. Whereas in E staining is absent from the granule cells and their dendritic fields, in F staining
is moderate to intense, outlining the granule cell somata and apical dendrites. G, H, In these TLE specimens with HS, a3-subunit immunoreactivity is
either absent in dentate gyrus (G) or, in H shows the same staining pattern as the a1-and a2-subunits. Note the variable size of granule cells. Scale bar,
25 mm.
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between the autopsy group and non-HS cases. Except for a clear
decrease in the subgranular layer, a3-subunit OD was not signifi-
cantly different in the HS group when compared to autopsy and
non-HS cases, which reflects the variable degree of granule cell
staining for this subunit in all three patient groups, as described
above.
DISCUSSION
Two principal conclusions emerge from this study. First, in the
normal human hippocampus a differential and neuron-specific ex-
pression pattern of GABAA receptor subtypes was evident, both at
the regional and the cellular level. Second, in TLE patients with
HS, staining was decreased in areas of prominent cell loss, whereas
surviving hippocampal neurons exhibited selective alterations in
the expression of the three major GABAA receptor subtypes. The
most striking changes were (1) increased staining for distinct
GABAA receptor subunits on the somata and apical dendrites of
granule cells with reduced labeling on the basal dendrites, (2)
differential reorganization of the a1-, a2-, and a3-subunits in the
CA2 area and in hilar cells, (3) partial and layer-specific loss of
a1-subunit-positive interneurons in the hippocampus proper, and
(4) altered dendritic morphology in many of the surviving inter-
neurons immunopositive for the a1-subunit.
GABAA receptor subtype expression in the normal
human hippocampus
In previous studies of human hippocampus, only antibodies for the
a1- and b2,3-subunits were available to determine GABAA recep-
tor distribution (Houser et al., 1988; Mizukami et al., 1997, 1998).
In addition, expression of the a5-subunit has been shown with
ligand binding and autoradiography (Sur et al., 1998; Howell et al.,
1999). Using an antigen-retrieval procedure adapted to human
brain tissue, specific immunostaining for the a2-, a3-, and g2-
subunits is now also possible (Loup et al., 1998). This has permitted
a comprehensive examination of the a1-, a2-, a3-, b2,3-, and
g2-subunits in the present investigation. Based on the staining
pattern of the ubiquitously expressed b2,3- and g2-subunits, we find
that the majority of hippocampal GABAA receptor subtypes ap-
pear to be labeled with the antibodies used.
GABAA receptor heterogeneity in the human hippocampus is
best demonstrated with the differential distribution of the a1-, a2-,
and a3-subunits, which represent markers of largely distinct recep-
tor subtypes. Thus, whereas all three a-subunits were present in
CA1, possibly in the same pyramidal cells, they were differentially
expressed in CA2 pyramidal cells, and only the a2-subunit was
detected in CA3 pyramidal cells. In the hilus, numerous morpho-
logically distinct cell types were observed, including a population
Figure 12. Upregulation of the GABAA receptor a2-subunit in the dentate gyrus of seven TLE specimens with HS in comparison to a control specimen
(autopsy). An overview of the hippocampus is shown in color-coded video images. Adjacent sections stained for Nissl are represented in black and white
at higher magnification, with the upper blade of the dentate gyrus depicted to demonstrate granule cell density. In control hippocampus (top lef t panel ),
granule cells are tightly packed, forming a compact layer. In HS specimens with moderate granule cell loss, staining intensity in the molecular layer is higher
than in controls. In HS specimens with severe granule cell loss, the apparent intensity is similar to that in controls. Scale bars: Nissl, 0.5 mm; a2, 2 mm.
Loup et al. • Altered GABAA Receptor Subtypes in Human Epilepsy J. Neurosci., July 15, 2000, 20(14):5401–5419 5415
of a2-subunit-positive pyramidal-like cells located well within the
hilar borders. Mossy cells displayed strong staining for both the a1-
and the a2-subunits, but not the a3-subunit. Furthermore, many
interneurons throughout the hippocampus were positive for the
a1-, but not the a2- or a3-subunit.
The strong staining of a1-subunit-positive interneurons revealed
a wide variety of cell types in all hippocampal layers and through-
out the dentate gyrus. These cells also expressed the b2,3- and
g2-subunits, suggesting the presence of functional GABAA recep-
tors. According to their morphology and localization, it is likely
that these interneurons are a subset of GABA neurons, as reported
in human and rodent brain (Gao and Fritschy, 1994; Nusser et al.,
1995; Esclapez et al., 1996; Zhang et al., 1998). Compared to
rodent, however, a larger diversity in cell types and higher com-
plexity in the distribution of a1-subunit-positive interneurons was
observed in the human.
Our results differ in several additional respects from those in
rodent brain (Fritschy and Mo¨hler, 1995; Sperk et al., 1997). First,
the a3-subunit, which is virtually absent in rodent hippocampus,
was strongly expressed in the CA1 area and was present to varying
degrees in dentate granule cells. This finding, unique for the
a3-subunit in the dentate gyrus, is unlikely to represent an artifact,
as the staining intensity for the a3-subunit in CA1, subiculum, and
entorhinal cortex was highly comparable between specimens (Loup
et al., 1998). Rather, this may reflect a dynamic regulation of this
subunit in granule cells. Second, little or no a1-subunit staining was
apparent in human CA3 pyramidal cells, whereas moderate a1-
subunit immunoreactivity has been reported in rodent CA3 den-
dritic fields. Third, hilar mossy cells abundantly expressed both the
a1- and a2-subunits in human, whereas this has not been observed
in rodent. Fourth, prominent staining was observed on the basal
dendrites of dentate granule cells. Basal dendrites, which are usu-
ally absent in normal rat granule cells, are a common feature in
human brain (Seress and Mrzljak, 1987; Lim et al., 1997). These
species differences underscore the need for caution in interpreting
findings from animal models of human disease.
Altered GABAA receptor subtype expression in TLE
specimens with HS
The following factors must be considered in interpreting our re-
sults. First, the age at collection differed between the autopsy
subjects and the two surgical patient groups. In agreement with
others (Mizukami et al., 1997), we found no evidence of age-related
changes in GABAA receptor subunit immunoreactivity, and cell
Figure 13. Digital images from confocal laser-scanning microscopy illustrating the increase in GABAA receptor a1-subunit staining in the dentate granule
cell layer in TLE with HS specimens (B, C, E) versus controls (A, D). In control specimens, discrete a1-subunit immunoreactivity outlines the somata of
individual granule cells (A, D). In TLE specimens with HS, the surviving granule cells are larger and surrounded by intense staining along the surface
of the somata and apical dendrites. Images A, B, D, and E were each prepared as a stack of four adjacent optical sections at intervals of 0.35 mm (A, B)
and 0.25 mm (D, E), and image C is based on the superposition of 30 adjacent optical sections spaced by 0.35 mm. Scale bars: A–C, 20 mm; D, E, 10 mm.
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numbers appeared to be constant in the autopsy group. Second, the
method of procurement did not influence the quality of staining, as
shown in Figure 1. Tissue and receptor expression were well
preserved, even with postmortem intervals of up to 16 hr (Loup et
al., 1998). Third, all surgical TLE patients, with HS and without
HS, were receiving antiepileptic treatment and had undergone
surgical anesthesia. The strongest finding that argues against ther-
apeutically induced changes accounting for our results is the
marked difference in GABAA receptor expression in HS versus
non-HS specimens, even though both were taking similar medica-
tion. Furthermore, no differences in expression pattern between
autopsy controls and the non-HS group receiving antiepileptic
drugs were apparent.
The profound decrease in GABAA receptor staining in the CA1
and CA3 areas and dentate hilus, where cell loss was most severe,
is in agreement with results from other studies (Olsen et al., 1992;
Wolf et al., 1994; Koepp et al., 1996; Hand et al., 1997). More
importantly, however, the reorganization of GABAA receptors
with maintained or increased levels of intensity in areas of relative
cell loss points to an increase in the number of receptors per
neuron. This was most apparent for the a2-subunit, indicating a
relative increase in GABAA receptors containing this subunit. The
fact that such changes were not recognized in previous investiga-
tions may reflect the lower spatial resolution of autoradiography
and PET analysis and an unavailability of subunit-specific ligands.
The strongest evidence for an upregulation of GABAA receptors
in individual cells was observed in the dentate gyrus. Similar
findings have been obtained in several animal models of TLE
(Schwarzer et al., 1997; Brooks-Kayal et al., 1998; Nusser et al.,
1998; Bouilleret et al., 2000). Upregulation has been proposed to
result from hyperactivity at GABA synapses in dentate granule
cells (Schwartzkroin, 1998). This hypothesis is supported by the
demonstration of activity-dependent changes in GABAA receptor
expression in animal models of TLE (Brooks-Kayal et al., 1998;
Nusser et al., 1998) and observations of reorganized axonal circuits
involving GABA neurons in human dentate molecular layer (Babb
et al., 1989; de Lanerolle et al., 1989; Mathern et al., 1995b, 1999;
Blu¨mcke et al., 1996).
A further interesting finding was the significant reduction in
staining in granule cell basal dendrites, even though these are
conserved in TLE with HS (Scheibel et al., 1974; Isokawa et al.,
1993; von Campe et al., 1997). Thus, there appears to be a redis-
tribution of GABAA receptors within granule cells with increased
expression in apical and decreased expression in basal dendrites.
These alterations may be compensatory in response to the recur-
rent excitation because of mossy fiber sprouting in HS (de Laner-
olle et al., 1989; Sutula et al., 1989; Houser et al., 1990; Babb et al.,
1991; Zhang and Houser, 1999). Paradoxically, however, the reor-
ganized mossy fibers may ultimately contribute to failure of
GABAA receptor function via a zinc-dependent mechanism (Buhl
et al., 1996; Brooks-Kayal et al., 1998; Shumate et al., 1998).
Aberrant mossy fiber innervation has also been described in the
CA2 area of TLE patients with HS (Houser et al., 1990; Babb et al.,
1992; Williamson and Spencer, 1994). Furthermore, CA2 pyrami-
dal cells in HS appear not to exhibit epileptiform bursts (William-
son and Spencer, 1994). The altered subcellular distribution and
expression of the a-subunit variants in CA2 pyramidal cells, which
was highly subunit-specific, may represent a structural correlate to
this functional finding.
Although substantial hilar cell loss is typical of HS, we show that
a number of cell types remained, including mossy cells, which
expressed the a1- and a2-subunits, and a subset of interneurons
positive for the a1-subunit. Mossy cells were clearly less prevalent
than in controls, yet represented a sizable proportion of the sur-
viving neurons labeled for both subunits, indicating that not all are
similarly vulnerable to injury. Among a1-subunit-positive interneu-
rons, mostly large multipolar cells were preserved. In dentate hilus,
loss of specific subpopulations of GABA neurons (de Lanerolle et
al., 1989; Robbins et al., 1991; Mathern et al., 1995b; Maglo´czky et
al., 2000), as well as preservation of other subclasses (Babb et al.,
1989; Sloviter et al., 1991; Mathern et al., 1995b; Blu¨mcke et al.,
1996; Maglo´czky et al., 2000), have been reported. This highly
differentiated sensitivity to seizure-induced damage underscores
the functional and neurochemical specialization of inhibitory cells
(Freund and Buzsa´ki, 1996). Furthermore, many of the surviving
hilar interneurons exhibited marked changes in dendritic morphol-
ogy, as reported recently using intracellular dye injections (Blu¨m-
cke et al., 1999) or immunohistochemical methods (Maglo´czky et
al., 2000). In our study, moreover, these alterations were also
observed in surviving interneurons located in the CA1-CA3 areas.
Future quantitative studies will aim at further characterization of
dendritic structure.
We observed a massive loss of a1-subunit-positive interneurons
in the CA2 and CA3 pyramidal cell layer. Conceivably, these cells
might have survived, but no longer express the a1-subunit-
containing receptor subtype. This is, however, unlikely on the basis
of studies of other neurochemical markers (see above). Laminar
loss of a subpopulation of interneurons, which has not been re-
ported before in human or animal models of TLE, suggests that
inhibitory drive is altered at specific inputs on surviving neurons in
stratum pyramidale.
In conclusion, we have provided the first comprehensive descrip-
tion of the organization of the three major GABAA receptor
subtypes in the human hippocampus. These results reveal a re-
markable complexity in GABAA receptor subunit expression,
which may be necessary to fulfill specific functional requirements
of distinct inhibitory neuronal circuits. Furthermore, our analysis
of hippocampal specimens from TLE patients with HS shows
marked changes in GABAA receptors with reorganization of spe-
cific receptor subtypes in surviving principal cells and interneu-
rons. These findings, unique to the human brain, will be of impor-
tance in the design of novel diagnostic and therapeutic strategies.
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